Detalles de la búsqueda
1.
Design and methods of an open-label, randomized controlled trial to evaluate the effect of pemafibrate on proteinuria in CKD patients (PROFIT-CKD).
Clin Exp Nephrol;
27(4): 358-364, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36738362
2.
Incidence of end-stage renal disease and risk factors for progression of renal dysfunction in Japanese patients with type 2 diabetes: the Fukuoka Diabetes Registry.
Clin Exp Nephrol;
26(2): 122-131, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34581896
3.
Changes in GFR and Albuminuria in Routine Clinical Practice and the Risk of Kidney Disease Progression.
Am J Kidney Dis;
78(3): 350-360.e1, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33895181
4.
Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS Program.
Am J Kidney Dis;
77(1): 23-34.e1, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32971190
5.
The comparative effects of intensive glucose lowering in diabetes patients aged below or above 65 years: Results from the ADVANCE trial.
Diabetes Obes Metab;
23(6): 1292-1300, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33539672
6.
Constipation and diabetic kidney disease: The Fukuoka Diabetes Registry.
Clin Exp Nephrol;
25(11): 1247-1254, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34173920
7.
Different eGFR Decline Thresholds and Renal Effects of Canagliflozin: Data from the CANVAS Program.
J Am Soc Nephrol;
31(10): 2446-2456, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32694216
8.
Sex-specific associations between cardiovascular risk factors and myocardial infarction in patients with type 2 diabetes: The ADVANCE-ON study.
Diabetes Obes Metab;
22(10): 1818-1826, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32476250
9.
Intensive glucose-lowering and the risk of vascular events and premature death in patients with decreased kidney function: The ADVANCE trial.
Diabetes Obes Metab;
22(3): 452-457, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31486188
10.
Clinical outcomes with canagliflozin according to baseline body mass index: results from post hoc analyses of the CANVAS Program.
Diabetes Obes Metab;
22(4): 530-539, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31729107
11.
Effect of Canagliflozin on Renal and Cardiovascular Outcomes across Different Levels of Albuminuria: Data from the CANVAS Program.
J Am Soc Nephrol;
30(11): 2229-2242, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31530577
12.
Diabetes as a risk factor for heart failure in women and men: a systematic review and meta-analysis of 47 cohorts including 12 million individuals.
Diabetologia;
62(9): 1550-1560, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31317230
13.
The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study.
Diabetologia;
62(11): 1988-1997, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31302707
14.
Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function.
Circulation;
138(15): 1537-1550, 2018 10 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29941478
15.
Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta-analysis.
Diabetes Obes Metab;
21(5): 1237-1250, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30697905
16.
Sex differences in the association between diabetes and cancer: a systematic review and meta-analysis of 121 cohorts including 20 million individuals and one million events.
Diabetologia;
61(10): 2140-2154, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30027404
17.
Use of the waist-to-height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE-ON study.
Diabetes Obes Metab;
20(8): 1903-1910, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29603537
18.
Serum adiponectin predicts fracture risk in individuals with type 2 diabetes: the Fukuoka Diabetes Registry.
Diabetologia;
60(10): 1922-1930, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28721438
19.
The gene-treatment interaction of paraoxonase-1 gene polymorphism and statin therapy on insulin secretion in Japanese patients with type 2 diabetes: Fukuoka diabetes registry.
BMC Med Genet;
18(1): 146, 2017 12 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29233102
20.
Proposed Cutoff Value of Brachial-Ankle Pulse Wave Velocity for the Management of Hypertension.
Circ J;
81(10): 1540-1542, 2017 Sep 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-28835589